New pill shows promise for controlling adult ADHD symptoms
NCT ID NCT05972044
Summary
This large study tested whether a daily medication called solriamfetol could help control symptoms in adults with ADHD. Over 500 adults took either the medication or a placebo pill for six weeks. Researchers measured changes in ADHD symptoms to see if the treatment was effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADHD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Site
Encino, California, 91316, United States
-
Clinical Research Site
Garden Grove, California, 92845, United States
-
Clinical Research Site
Newport Beach, California, 92660, United States
-
Clinical Research Site
Riverside, California, 92506, United States
-
Clinical Research Site
Santa Ana, California, 92705, United States
-
Clinical Research Site
Sherman Oaks, California, 91403, United States
-
Clinical Research Site
Torrance, California, 90504, United States
-
Clinical Research Site
Walnut Creek, California, 94596, United States
-
Clinical Research Site
Colorado Springs, Colorado, 80910, United States
-
Clinical Research Site
Clermont, Florida, 34711, United States
-
Clinical Research Site
Doral, Florida, 33122, United States
-
Clinical Research Site
Gainesville, Florida, 32607, United States
-
Clinical Research Site
Jacksonville, Florida, 32256, United States
-
Clinical Research Site
Lauderhill, Florida, 33319, United States
-
Clinical Research Site
Miami Lakes, Florida, 33016, United States
-
Clinical Research Site
Orlando, Florida, 32801, United States
-
Clinical Research Site
Marietta, Georgia, 30060, United States
-
Clinical Research Site
Overland Park, Kansas, 66210, United States
-
Clinical Research Site
Boston, Massachusetts, 02131, United States
-
Clinical Research Site
Saint Charles, Missouri, 63304, United States
-
Clinical Research Site
Lincoln, Nebraska, 68526, United States
-
Clinical Research Site
Las Vegas, Nevada, 89102, United States
-
Clinical Research Site
Las Vegas, Nevada, 89128, United States
-
Clinical Research Site
Berlin, New Jersey, 08009, United States
-
Clinical Research Site
Cherry Hill, New Jersey, 08002, United States
-
Clinical Research Site
Princeton, New Jersey, 08540, United States
-
Clinical Research Site
Mount Kisco, New York, 10549, United States
-
Clinical Research Site
New York, New York, 10128, United States
-
Clinical Research Site
Raleigh, North Carolina, 27609, United States
-
Clinical Research Site
Cincinnati, Ohio, 45219, United States
-
Clinical Research Site
Kettering, Ohio, 45439, United States
-
Clinical Research Site
Oklahoma City, Oklahoma, 73116, United States
-
Clinical Research Site
Media, Pennsylvania, 19063, United States
-
Clinical Research Site
North Charleston, South Carolina, 29405, United States
-
Clinical Research Site
Memphis, Tennessee, 38119, United States
-
Clinical Research Site
Austin, Texas, 78737, United States
-
Clinical Research Site
Bellaire, Texas, 77401, United States
-
Clinical Research Site
Dallas, Texas, 75243, United States
-
Clinical Research Site
Dallas, Texas, 75251, United States
-
Clinical Research Site
San Antonio, Texas, 78229, United States
-
Clinical Research Site
Draper, Utah, 84020, United States
-
Clinical Research Site
Everett, Washington, 98201, United States
Conditions
Explore the condition pages connected to this study.